These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes. Casey DE. Psychopharmacol Ser; 1993 Jan; 10():101-10. PubMed ID: 8103220 [No Abstract] [Full Text] [Related]
7. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Arch Gen Psychiatry; 1992 Jul; 49(7):538-44. PubMed ID: 1352677 [Abstract] [Full Text] [Related]
8. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. Janssen PA, Niemegeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF. J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200 [Abstract] [Full Text] [Related]
9. Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors. Coffin VL, Latranyi MB, Chipkin RE. J Pharmacol Exp Ther; 1989 Jun; 249(3):769-74. PubMed ID: 2567351 [Abstract] [Full Text] [Related]
11. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M, Shirakawa K, Matsuoka N, Mutoh S. Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [Abstract] [Full Text] [Related]
12. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone. Markianos M, Hatzimanolis J, Lykouras L. Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043 [Abstract] [Full Text] [Related]
15. New and old antipsychotics versus clozapine in a monkey model: adverse effects and antiamphetamine effects. Peacock L, Gerlach J. Psychopharmacology (Berl); 1999 Jun; 144(3):189-97. PubMed ID: 10435384 [Abstract] [Full Text] [Related]
16. Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol. Peacock L, Gerlach J. Eur J Pharmacol; 1993 Jun 24; 237(2-3):329-40. PubMed ID: 8103465 [Abstract] [Full Text] [Related]
19. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M, Kumar A, Chopra K, Kulkarni SK. Indian J Exp Biol; 2007 Feb 24; 45(2):175-9. PubMed ID: 17375557 [Abstract] [Full Text] [Related]